115 Participants Needed

Transition Care Program for Type 1 Diabetes

(SHIFT2 Trial)

SF
LC
Overseen ByLaura Caccavale
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Virginia Commonwealth University

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help adolescents and young adults with type 1 diabetes transition from pediatric to adult medical care. It tests a transition preparation program that includes coaching sessions and supportive messages to encourage self-management of diabetes. Participants will be divided into two groups: one receiving the full program with sessions and messages, and another receiving regular medical visits and monthly educational materials. Suitable candidates have had type 1 diabetes for at least a year, are patients at the Children's Hospital of Richmond, speak English, and have a caregiver willing to participate.

As an unphased trial, this study offers a unique opportunity to enhance the transition to adult care with personalized support.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this transition preparation program is safe for adolescents and young adults with type 1 diabetes?

Research shows that programs designed to help young adults with type 1 diabetes transition to adult care are safe and well-received. Studies have found that these programs assist young people in moving to adult healthcare smoothly. Participants reported no serious issues during or after these programs. The main goal is to help young adults manage their diabetes more effectively as they age.

In other studies, young adults and their parents participated in a 6-month program to prepare for the switch to adult healthcare. This program succeeded without causing any negative effects. Participants found it useful for learning to manage their condition independently.

Overall, the transition preparation program is a proven safe way to support young people with type 1 diabetes.12345

Why are researchers excited about this trial?

Researchers are excited about this Transition Care Program for Type 1 Diabetes because it focuses on empowering young people during a crucial transition period. Unlike standard care, which typically involves regular medical visits and general education, this program offers a personalized approach with sessions led by a transition coach, encouraging self-management behaviors through bi-weekly messages. Additionally, it involves parents by providing them with resources to support their child's transition, which isn't a common feature in existing treatments. This holistic and supportive approach aims to smooth the transition from pediatric to adult care, potentially improving long-term diabetes management for adolescents and young adults.

What evidence suggests that this transition preparation program is effective for adolescents and young adults with type 1 diabetes?

Research has shown that a transition preparation program can help teenagers and young adults with type 1 diabetes manage their condition better as they move from child to adult healthcare. In this trial, participants in Group A will engage in the SHIFT2 program, which aims to improve outcomes by teaching self-care skills and offering support during this important time. Studies have found that many young people with type 1 diabetes struggle to maintain their blood sugar levels within the target range during this transition. Programs like SHIFT have been linked to fewer breaks in care and fewer diabetes-related problems. Meanwhile, participants in Group B will receive educational materials as part of routine medical visits. Overall, these programs aim to make the transition to adult care smoother and safer for young people with type 1 diabetes.23678

Who Is on the Research Team?

LC

Laura Caccavale

Principal Investigator

Virginia Commonwealth University

Are You a Good Fit for This Trial?

This trial is for English-speaking adolescents and young adults aged 16-22 with Type 1 Diabetes, who have been patients at the Children's Hospital of Richmond for over a year. They must have a caregiver over 18 willing to participate. Excluded are those with psychiatric disorders, non-Type 1 diabetes, recent severe mental health issues, current pregnancy or breastfeeding, or involvement in conflicting studies.

Inclusion Criteria

AYA: must have a caregiver willing to participate
I have had Type 1 Diabetes for at least a year.
You are a patient at the Children's Hospital of Richmond in the Division of Pediatric Endocrinology.
See 2 more

Exclusion Criteria

AYA: Another member of the household (other than the participating parent) is a participant or staff member on this study
Caregiver: Participation in another research study that may interfere with current study
Caregiver: Another member of the home (not AYA) is a participant/staff member on current study
See 11 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 6-month transition preparation program with monthly sessions and bi-weekly messages for diabetes management

6 months
6 visits (in-person), bi-weekly virtual messages

Follow-up

Participants are monitored for changes in diabetes distress, support, adherence, self-efficacy, quality of life, and HbA1C

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Educational materials
  • Transition preparation program
Trial Overview The study evaluates a transition preparation program aimed at supporting young individuals with Type 1 Diabetes as they shift from pediatric to adult medical care. It includes educational materials and involves both the patient and their caregiver to improve self-management before transitioning.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group A: SHIFT2Experimental Treatment1 Intervention
Group II: Group B: TAU+/ControlPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Virginia Commonwealth University

Lead Sponsor

Trials
732
Recruited
22,900,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Published Research Related to This Trial

A systematic review of 43 studies involving young people with Type 1 diabetes revealed that healthcare transitions are linked to worse clinic attendance, indicating a potential gap in care during this critical period.
While the impact on glycaemic control and hospitalizations was mixed, there is preliminary evidence suggesting that structured transition programs could improve experiences and outcomes for young patients navigating adult healthcare.
The experiences and impact of transition from child to adult healthcare services for young people with Type 1 diabetes: a systematic review.Sheehan, AM., While, AE., Coyne, I.[2022]
The study compared a comprehensive transition program (CTP) to standard clinical practice (SCP) for young people with type 1 diabetes mellitus transitioning to adult care, finding that both groups had high retention rates in adult services, but the CTP group had a higher baseline and follow-up HbA1c level.
Despite the lack of significant differences in retention or engagement, the study highlights the need for more randomized controlled trials to better understand effective transition strategies for young people with T1DM.
A pilot randomized controlled trial of a post-discharge program to support emerging adults with type 1 diabetes mellitus transition from pediatric to adult care.Steinbeck, KS., Shrewsbury, VA., Harvey, V., et al.[2022]
A survey of 602 young adults with type 1 diabetes revealed that many in the pediatric group (64%) stayed in pediatric care due to emotional attachment, highlighting the importance of emotional support during the transition to adult care.
Despite receiving counseling on diabetes management, less than half of the participants discussed reproductive health, indicating a gap in comprehensive care that needs to be addressed to improve transition outcomes.
Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes.Garvey, KC., Foster, NC., Agarwal, S., et al.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40529395/
Study protocol for the SHIFT randomized clinical trialWe present the design of Supporting Health Improvement for Transition in T1D (SHIFT), a randomized clinical trial of a clinic-based transition preparation ...
Study protocol for the SHIFT randomized clinical trialA striking 83 % of adolescents and young adults (AYA) with type 1 diabetes (T1D) have glycemic outcomes outside the target range, placing them at risk for ...
Opportunities for Enhanced Transition of Care Preparation for ...Opportunities for enhanced transition of care preparation for adolescents and emerging adults with type 1 diabetes: use of the READDY transition tool.
Transition and transfer experiences and their correlates in ...Experiences of transition to adulthood and transfer to adult care in young adults with type 1 diabetes: A qualitative study. J Adv Nurs 2023 ...
Development of a transition program for emerging adults ...A formal transition program can help prevent gaps in care, improve disease self-management skills, decrease disease burden, and reduce diabetes complications.
Evaluation of a Structured Transition Program for Young ...A structured transition program was successful in facilitating transition to adult care without a decrease in clinical follow-up.
Development and Implementation of a Pilot Transition ...Young adults and parents participated in a 6-month intervention designed to enhance transition readiness and independent diabetes management.
Transition Care Program for Type 1 Diabetes (SHIFT2 Trial)The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity